CVS Health Corporation's PBM Strong, but Retail Business Weak in 2nd Quarter
CVS Health (NYSE: CVS) didn't disappoint the last time the pharmacy giant announced its quarterly results. The company's profit was down in the first quarter, but still beat expectations. Still, CVS Health has referred to 2017 as "a rebuilding year."
The company announced its second-quarter results before the market opened on Tuesday. Did CVS Health take another positive step in its rebuilding effort? Here are the highlights from the company's second-quarter update.
Image source: Getty Images.
Source: Fool.com
CVS Health Corp. Aktie
56,19 €
3,77 %
Klare Kaufstimmung: CVS Health Corp. hat 27 Buy-Einschätzungen und keine Sell-Einschätzung.
Ein Kursziel von 79 € für CVS Health Corp. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 56.19 € bedeuten.
